Seattle institute shares favorable results for malaria vaccine

06/30/2009 | Seattle Times, The

Researchers at Seattle Biomedical Research Institute have successfully engineered the genes of malaria-carrying parasites and used these to create an experimental vaccine that proved 100% effective in tests on rats and mice. The researchers plan to test the vaccine candidate on humans next year.

View Full Article in:

Seattle Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA